UCB to acquire maker of antibody treatments for autoimmune diseases

A second shot at gene therapy for Huntington's, China's tightening grip on pharma supply chains, and more Readout biotech updates

More from STAT

Supreme Court restores access to abortion pill mifepristone through telehealth, mail, and pharmacies

STAT·1

Pump the brakes on AI, buddy; and deposition deadlock

STAT·5

What to know about hantavirus, the illness suspected in a cruise ship outbreak

STAT·6

STAT+: Pharmalittle: We’re reading about an abortion pill controversy, another UCB deal, and more news

STAT·2

Federal court blocks mailing of mifepristone

STAT·5

STAT+: Biotech raises $42 million to run Huntington’s disease trial

STAT·7